Results 271 to 280 of about 39,319 (333)

Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis. [PDF]

Blood Adv
Pidala J, Kim J, Kalos D, Cutler C, DeFilipp Z, Flowers MED, Hamilton BK, Chin KK, Rotta M, El Jurdi N, Hamadani M, Ahmed G, Kitko C, Ponce D, Sung A, Tang H, Farhadfar N, Nemecek E, Pusic I, Qayed M, Rangarajan H, Hogan W, Etra A, Jaglowski S.   +23 more
europepmc   +1 more source

Lactobacillus gasseri prevents ibrutinib-associated atrial fibrillation through butyrate. [PDF]

Europace
Shi L, Duan Y, Fang N, Zhang N, Yan S, Wang K, Hou T, Wang Z, Jiang X, Gao Q, Zhang S, Li Y, Zhang Y, Gong Y.   +13 more
europepmc   +1 more source

Computational molecular insights into ibrutinib as a potent inhibitor of HER2-L755S mutant in breast cancer: gene expression studies, virtual screening, docking, and molecular dynamics analysis. [PDF]

Front Mol Biosci
Loganathan T, George Priya Doss C.
europepmc   +1 more source

Oncoral Follow-Up for Outpatients Treated with Oral Anticancer Drugs Assessed by Relative Dose Intensity. [PDF]

Pharmaceuticals (Basel)
Larbre V, Ranchon F, Maucort-Boulch D, Coz E, Herledan C, Caffin AG, Baudouin A, Maire M, Romain-Scelle N, Vacheron CH, Karlin L, Salles G, Ghesquières H, Rioufol C.   +13 more
europepmc   +1 more source

Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma. [PDF]

J Exp Clin Cancer Res
Wang J, Liu X, Hong Y, Wang S, Chen P, Gu A, Guo X, Zhao P.   +7 more
europepmc   +1 more source

Inhibition of Putative Ibrutinib Targets Promotes Atrial Fibrillation, Conduction Blocks, and Proarrhythmic Electrocardiogram Indices: A Mendelian Randomization Analysis. [PDF]

Cancer Innov
Xu H, Li B, Lv P, Chen Y, Lin Y, Zhang A, Zhao J, Zhou G, Wu L.   +8 more
europepmc   +1 more source

Transcriptomic profiling in canine B-cell lymphoma supports a synergistic effect of BTK and PI3K inhibitors. [PDF]

Front Vet Sci
Lainscsek X, Kong W, Rütgen BC, Beck J, Brenig B, Nolte I, Murua Escobar H, Taher L.   +7 more
europepmc   +1 more source

Greek Consensus on Chronic Lymphocytic Leukemia (CLL) Treatment. [PDF]

Mediterr J Hematol Infect Dis
Sachanas S, Vassilakopoulos T, Angelopoulou M, Papageorgiou S, Spanoudakis E, Bouzani M, Dimou M, Panagiotidis P.   +7 more
europepmc   +1 more source

Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH). [PDF]

Hematol Transfus Cell Ther
Chiattone CS, Marques FM, Buccheri V, Yamamoto M, Fortier SC, Ikoma-Colturato MRV, Hamerschlak N, Figueiredo VLP, da Silveira TMB, Costa A, Laks D, Schaffel R, Barreto WG, Scheliga A, Fernandes PA, Nabhan SK, Gaiolla RD, Gonçalves MV, de Farias DLC, Ribeiro G, de Lacerda MP, Arrais-Rodrigues C, Brazilian Group of Chronic Lymphocytic Leukemia.   +22 more
europepmc   +1 more source

Functional proteoform group deconvolution reveals a broader spectrum of ibrutinib off-targets. [PDF]

Nat Commun
Leo IR, Kunold E, Audrey A, Tampere M, Eirich J, Lehtiö J, Jafari R.   +6 more
europepmc   +1 more source